Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilbert Bensimon

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Skeletal Radiology|November 15, 2011
Value of percutaneous radiofrequency ablation with or without percutaneous vertebroplasty for pain relief and functional recovery in painful bone metastasesFrédéric Clarençon, Betty Jean, Hang-Phuong Pham, et al.
Plos One|September 21, 2011
The economic costs of progressive supranuclear palsy and multiple system atrophy in France, Germany and the United KingdomPaul McCrone, Christine Anne Mary Payan, Martin Knapp, et al.
The Lancet. Neurology|March 12, 2018
Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging studyTon Fang, Ahmad Al Khleifat, Jacques-Henri Meurgey, et al.
The Lancet. Neurology|June 20, 2018
Stage of prolonged survival in ALS - Author's replyAmmar Al-Chalabi, Ton Fang, Ahmad Al Khleifat, et al.
Journal of the Neurological Sciences|January 16, 2002
Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patientsOdile Spreux-Varoquaux, Gilbert Bensimon, Lucette Lacomblez, et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|June 19, 2004
Efficacy and safety of xaliproden in amyotrophic lateral sclerosis: results of two phase III trialsVincent Meininger, Gilbert Bensimon, Walter R Bradley, et al.
The Lancet. Diabetes & Endocrinology|March 14, 2014
Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trialAgnès Hartemann, Gilbert Bensimon, Christine A Payan, et al.
Plos One|October 23, 2010
Platelet serotonin level predicts survival in amyotrophic lateral sclerosisLuc Dupuis, Odile Spreux-Varoquaux, Gilbert Bensimon, et al.
Stem Cells (Dayton, Ohio)|August 5, 2006
Bone marrow transplantation attenuates the myopathic phenotype of a muscular mouse model of spinal muscular atrophyNouzha Salah-Mohellibi, Gaelle Millet, Isabelle André-Schmutz, et al.
Brain : a Journal of Neurology|June 26, 2010
Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsyRichard G Brown, Lucette Lacomblez, Bernard G Landwehrmeyer, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Skeletal Radiology|November 15, 2011
Value of percutaneous radiofrequency ablation with or without percutaneous vertebroplasty for pain relief and functional recovery in painful bone metastasesFrédéric Clarençon, Betty Jean, Hang-Phuong Pham, et al.
Plos One|September 21, 2011
The economic costs of progressive supranuclear palsy and multiple system atrophy in France, Germany and the United KingdomPaul McCrone, Christine Anne Mary Payan, Martin Knapp, et al.
The Lancet. Neurology|March 12, 2018
Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging studyTon Fang, Ahmad Al Khleifat, Jacques-Henri Meurgey, et al.
The Lancet. Neurology|June 20, 2018
Stage of prolonged survival in ALS - Author's replyAmmar Al-Chalabi, Ton Fang, Ahmad Al Khleifat, et al.
Journal of the Neurological Sciences|January 16, 2002
Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patientsOdile Spreux-Varoquaux, Gilbert Bensimon, Lucette Lacomblez, et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|June 19, 2004
Efficacy and safety of xaliproden in amyotrophic lateral sclerosis: results of two phase III trialsVincent Meininger, Gilbert Bensimon, Walter R Bradley, et al.
The Lancet. Diabetes & Endocrinology|March 14, 2014
Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trialAgnès Hartemann, Gilbert Bensimon, Christine A Payan, et al.
Plos One|October 23, 2010
Platelet serotonin level predicts survival in amyotrophic lateral sclerosisLuc Dupuis, Odile Spreux-Varoquaux, Gilbert Bensimon, et al.
Stem Cells (Dayton, Ohio)|August 5, 2006
Bone marrow transplantation attenuates the myopathic phenotype of a muscular mouse model of spinal muscular atrophyNouzha Salah-Mohellibi, Gaelle Millet, Isabelle André-Schmutz, et al.
Brain : a Journal of Neurology|June 26, 2010
Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsyRichard G Brown, Lucette Lacomblez, Bernard G Landwehrmeyer, et al.
Pageof 4